Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
450 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00507702 | Identification of Key Blood Molecular Markers for Immunotherapy | terminated | — | 191 | Stanford UniversityOTHER | 1 | Apr 18, 2019 | clinicaltrials |
| NCT00695968 | Breast Density and the Role of Preoperative Mammography, Ultrasound, Elastography and MRI | terminated | — | 9 | Stanford UniversityOTHER | 1 | Apr 18, 2019 | clinicaltrials |
| NCT01060319 | A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies | withdrawn | — | 0 | Stanford UniversityOTHER | 1 | Apr 18, 2019 | clinicaltrials |
| NCT01011842 | Real-Time kV Imaging vs. Real-Time 3D Patient Surface Tracking for Head & Neck Cancer | terminated | N/A | 11 | Stanford UniversityOTHER | 1 | Apr 9, 2019 | clinicaltrials |
| NCT03245788 | Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study | completed | N/A | 1,053 | Stanford UniversityOTHER | 1 | Apr 8, 2019 | clinicaltrials |
| NCT01162018 | Acupuncture for Sleep Disruption in Cancer Survivors | completed | N/A | 65 | Stanford UniversityOTHER | 1 | Apr 4, 2019 | clinicaltrials |
| NCT02365844 | Multispectral Imaging to Characterize Patterns of Vascular Supply Within Lymphoepithelial Mucosa in Oropharyngeal Cancer | completed | — | 81 | Stanford UniversityOTHER | 1 | Mar 1, 2019 | clinicaltrials |
| NCT01048060 | Consent for Obtaining Additional Bone Marrow Specimens at Time of Diagnostic Bone Marrow Procedure | terminated | — | 334 | Stanford UniversityOTHER | 1 | Feb 11, 2019 | clinicaltrials |
| NCT03049358 | Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal Cancer | terminated | N/A | 15 | Stanford UniversityOTHER | 1 | Feb 5, 2019 | clinicaltrials |
| NCT03819920 | Does Knowing One's Estimated Colorectal Cancer Risk Influence Screening Behavior? | completed | N/A | 229 | Stanford UniversityOTHER | 1 | Feb 5, 2019 | clinicaltrials |
| NCT03206216 | Feasibility Study of New Method of Diagnostic and Prediction of Painful CIPN | terminated | N/A | 1 | Stanford UniversityOTHER | 1 | Dec 19, 2018 | clinicaltrials |
| NCT00267787 | Molecular Genetic and Pathological Studies of Anal Tumors | terminated | — | 7 | Stanford UniversityOTHER | 1 | Dec 10, 2018 | clinicaltrials |
| NCT01011218 | Management of Insomnia in Breast Cancer Patients | completed | Phase 2 | 70 | Stanford UniversityOTHER | 1 | Nov 29, 2018 | clinicaltrials |
| NCT02530606 | Photoacoustic Imaging in Detecting Ovarian or Fallopian Tube Cancer | withdrawn | N/A | 0 | Stanford UniversityOTHER | 1 | Nov 28, 2018 | clinicaltrials |
| NCT01769209 | Bortezomib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia | completed | Phase 2 | 18 | Stanford UniversityOTHER | 1 | Nov 14, 2018 | clinicaltrials |
| NCT01108094 | Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients w/ Basal Cell Carcinomas | completed | Phase 2 | 29 | Stanford UniversityOTHER | 1 | Nov 13, 2018 | clinicaltrials |
| NCT01805141 | Phase I Pilot Study to Evaluate the Prognostic Value of Perfusion CT for Primary Cervical Cancer | completed | — | 24 | Stanford UniversityOTHER | 1 | Oct 31, 2018 | clinicaltrials |
| NCT02966509 | Engagement of Patients With Advanced Cancer(EPAC) | completed | N/A | 213 | Stanford UniversityOTHER | 0 | Oct 31, 2018 | clinicaltrials |
| NCT01904643 | Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | terminated | Phase 1 | 17 | Stanford UniversityOTHER | 1 | Oct 29, 2018 | clinicaltrials |
| NCT02728700 | Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT | terminated | Phase 1 | 1 | Stanford UniversityOTHER | 1 | Sep 12, 2018 | clinicaltrials |
| NCT01460641 | Perfusion CT as a Predictor of Treatment Response in Patients With Rectal Cancer | completed | — | 21 | Stanford UniversityOTHER | 1 | Sep 7, 2018 | clinicaltrials |
| NCT02529332 | Omega-3 Supplementation for Smell Dysfunction | completed | N/A | 110 | Stanford UniversityOTHER | 1 | Aug 21, 2018 | clinicaltrials |
| NCT00026208 | Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma | completed | Phase 2 | 76 | Stanford UniversityOTHER | 1 | Jul 24, 2018 | clinicaltrials |
| NCT00890929 | Phase 1-2 of Azacitidine + Lenalidomide for Previously Untreated Elderly Patients With Acute Myeloid Leukemia (AML) | completed | Phase 1 / Phase 2 | 45 | Stanford UniversityOTHER | 1 | Jun 18, 2018 | clinicaltrials |
| NCT01791894 | Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma(ATO) | completed | Phase 1 / Phase 2 | 5 | Stanford UniversityOTHER | 1 | Jun 8, 2018 | clinicaltrials |
| NCT01162031 | Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia | withdrawn | Phase 2 | 0 | Stanford UniversityOTHER | 1 | May 21, 2018 | clinicaltrials |
| NCT01835288 | Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | withdrawn | Phase 2 | 0 | Stanford UniversityOTHER | 0 | May 21, 2018 | clinicaltrials |
| NCT00482053 | Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT | terminated | Phase 2 | 3 | Stanford UniversityOTHER | 1 | May 14, 2018 | clinicaltrials |
| NCT02723435 | Midostaurin in Treating Older Patients With Mutated Acute Myeloid Leukemia Post-Transplant | withdrawn | Phase 2 | 0 | Stanford UniversityOTHER | 0 | May 4, 2018 | clinicaltrials |
| NCT01314963 | Efficacy of Gamma Camera Used Intraoperatively for ID of Sentinel Lymph Nodes w/ Lymphoscintigraphy | completed | N/A | 50 | Stanford UniversityOTHER | 1 | Apr 30, 2018 | clinicaltrials |
| NCT01188486 | Pulmonary Interstitial Lymphography in Early Stage Lung Cancer | terminated | N/A | 12 | Stanford UniversityOTHER | 1 | Apr 17, 2018 | clinicaltrials |
| NCT01970670 | Contrast-Enhanced Digital Mammography(CEDM) vs Contrast-Enhanced Breast MRI(CE-MRI) in Breast Cancer | completed | — | 50 | Stanford UniversityOTHER | 1 | Apr 17, 2018 | clinicaltrials |
| NCT01823679 | Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin | terminated | Phase 2 | 2 | Stanford UniversityOTHER | 1 | Apr 12, 2018 | clinicaltrials |
| NCT01055028 | Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma | terminated | Phase 2 | 18 | Stanford UniversityOTHER | 1 | Mar 26, 2018 | clinicaltrials |
| NCT02488070 | 68Ga-PSMA PET/CT or PET/MRI in Evaluating Patients With Recurrent Prostate Cancer | completed | Phase 1 / Phase 2 | 10 | Stanford UniversityOTHER | 1 | Mar 20, 2018 | clinicaltrials |
| NCT01284504 | Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer | terminated | N/A | 1 | Stanford UniversityOTHER | 1 | Mar 16, 2018 | clinicaltrials |
| NCT00481832 | Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma | terminated | Phase 2 | 50 | Stanford UniversityOTHER | 1 | Feb 14, 2018 | clinicaltrials |
| NCT01442714 | Azacitidine + Lenalidomide Combo in the Elderly With Previously Treated AML & High-Risk MDS | terminated | Phase 2 | 33 | Stanford UniversityOTHER | 1 | Jan 3, 2018 | clinicaltrials |
| NCT01146054 | Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma | completed | Phase 2 | 59 | Stanford UniversityOTHER | 1 | Dec 19, 2017 | clinicaltrials |
| NCT00349778 | High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma | completed | Phase 2 | 102 | Stanford UniversityOTHER | 1 | Dec 12, 2017 | clinicaltrials |
| NCT01771666 | Pilot Indocyanine Green Imaging for Mapping of Arm Draining Lymphatics & Nodes in Breast Cancer | completed | Phase 2 | 23 | Stanford UniversityOTHER | 1 | Dec 11, 2017 | clinicaltrials |
| NCT01631331 | Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC) | completed | Early Phase 1 | 15 | Stanford UniversityOTHER | 1 | Dec 8, 2017 | clinicaltrials |
| NCT00656019 | Development of Vitamin D as a Therapy for Breast Cancer - Phase 2 | completed | Phase 2 | 63 | Stanford UniversityOTHER | 1 | Dec 2, 2017 | clinicaltrials |
| NCT01260909 | Real-Time MV/kV Image Guided Radiation Therapy | withdrawn | — | 0 | Stanford UniversityOTHER | 0 | Dec 2, 2017 | clinicaltrials |
| NCT00477087 | Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer | terminated | Phase 2 | 10 | Stanford UniversityOTHER | 1 | Nov 29, 2017 | clinicaltrials |
| NCT00186628 | Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD | completed | Phase 2 | 36 | Stanford UniversityOTHER | 1 | Nov 28, 2017 | clinicaltrials |
| NCT01313884 | Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma | terminated | Phase 2 | 3 | Stanford UniversityOTHER | 1 | Nov 24, 2017 | clinicaltrials |
| NCT01078350 | Consent for Obtaining Additional Tissue at the Time of a Diagnostic Biopsy | completed | — | 93 | Stanford UniversityOTHER | 1 | Nov 20, 2017 | clinicaltrials |
| NCT01187446 | Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides | terminated | Phase 1 / Phase 2 | 28 | Stanford UniversityOTHER | 1 | Nov 20, 2017 | clinicaltrials |
| NCT01123005 | Imaging and Biomarkers of Hypoxia in Solid Tumors | terminated | Phase 1 | 28 | Stanford UniversityOTHER | 1 | Nov 6, 2017 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials